Athersys to Host First Quarter Financial Results Call
April 10, 2017 11:00 ET
|
Athersys, Inc.
CLEVELAND, April 10, 2017 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq:ATHX) will release its first quarter 2017 financial results at approximately 4:00 PM Eastern Time on Tuesday, May 9, 2017, and...
Athersys to Present at Needham Healthcare Conference on April 4
March 29, 2017 16:00 ET
|
Athersys, Inc.
CLEVELAND, March 29, 2017 (GLOBE NEWSWIRE) -- Athersys, Inc. (NASDAQ:ATHX) announced today that Gil Van Bokkelen, Chairman and CEO, will present a corporate overview at the 16th Annual Needham...
Two New Publications Highlight the Potential for MultiStem® Treatment of Ischemic Stroke
March 20, 2017 06:30 ET
|
Athersys, Inc.
CLEVELAND, March 20, 2017 (GLOBE NEWSWIRE) -- Athersys, Inc. (NASDAQ:ATHX) announced today that clinical investigators have published results from Athersys’ Phase 2 trial of MultiStem cell therapy...
Athersys Reports Financial Results for Fourth Quarter, Full Year 2016
March 09, 2017 16:05 ET
|
Athersys, Inc.
Company also announces priority review designation obtained by Healios in Japan-accelerating potential approval pathway for MultiStem® clinical program for ischemic stroke Management to host...
Overview of MultiStem® Clinical Trial in Japan Presentation at International Stroke Conference 2017
February 23, 2017 07:00 ET
|
Athersys, Inc.
CLEVELAND, Feb. 23, 2017 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq:ATHX) announced today a presentation featuring its MultiStem® cell therapy treatment for ischemic stroke at the International...
Athersys to Host Year-End 2016 Financial Results Call
February 14, 2017 09:30 ET
|
Athersys, Inc.
CLEVELAND, Feb. 14, 2017 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq:ATHX) will release its year-end 2016 financial results at approximately 4:00 PM Eastern Time on Thursday, March 9, 2017, and will...
Athersys Announces Closing of Public Offering of Common Stock
February 01, 2017 16:05 ET
|
Athersys, Inc.
CLEVELAND, Feb. 01, 2017 (GLOBE NEWSWIRE) -- Athersys, Inc. (NASDAQ:ATHX) (“Athersys”) today announced the closing of its previously announced underwritten public offering of 22,772,300 shares of...
Athersys Announces Pricing of Public Offering of Common Stock
January 27, 2017 08:59 ET
|
Athersys, Inc.
CLEVELAND, Jan. 27, 2017 (GLOBE NEWSWIRE) -- Athersys, Inc. (NASDAQ:ATHX) (“Athersys”) today announced the pricing of its previously announced underwritten public offering of 19,802,000 shares of...
Athersys Announces Proposed Public Offering of Common Stock
January 26, 2017 16:28 ET
|
Athersys, Inc.
CLEVELAND, Jan. 26, 2017 (GLOBE NEWSWIRE) -- Athersys, Inc. (NASDAQ:ATHX) (“Athersys”) announced today that it intends to offer for sale shares of its common stock, par value $0.001 per share...
Athersys Subsidiary and Leading Animal Health Company Enter Into Research and Option Agreement for Cell Therapy
January 18, 2017 06:00 ET
|
Athersys, Inc.
CLEVELAND, Jan. 18, 2017 (GLOBE NEWSWIRE) -- Athersys, Inc. (NASDAQ:ATHX) announced today that through its Belgian subsidiary, ReGenesys BVBA (ReGenesys), it has entered into an agreement with a...